CAITLIN BEACH: Open Payments
NPI 1801133970 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 64 payments from 13 companies in 2025. Trend: 2023 $1,812 · 2024 $1,825 · 2025 $1,345
Food & beverage: $1,345
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $232 |
| ABBVIE INC. | 13 | $209 |
| GENZYME CORPORATION | 6 | $177 |
| Regeneron Healthcare Solutions, Inc. | 7 | $148 |
| Botanix SB Inc | 1 | $144 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $84 |
| UCB, Inc. | 2 | $60 |
| Amgen Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, SOFDRA, SPEVIGO, Odomzo, Bimzelx, OTEZLA.
Industry payments across FL — which companies pay providers there.
